TNFSF11 and osteoporosis: Another active compound that could be a promising product for the treatment of osteoporosis is tocotrienol, which protects against oxidative damage, reduces lipid peroxidation, activates of the Wnt/β-catenin signaling pathway, and lowers the RANKL/OPG ratio.